Over the past 12 months, MapLight Therapeutics insiders bought $66.23 million of stock on the open market (5.66Mn shares) and sold $30.24 million (1.12Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Inc. Catalyst4, | TenPercentOwner | 0 | 25,306,689 | 25,306,689 | 79.2% | 18 Aug, 2026 |
| 2 | Holdings A/S Novo | TenPercentOwner | 3,686,622 | 0 | 3,686,622 | 11.5% | 30 Oct, 2025 |
| 3 | Christopher A. Kroeger | Chief Executive Officer | 1,195,909 | 0 | 1,195,909 | 3.7% | 16 Oct, 2026 |
| 4 | Vishwas Setia | Chief Financial Officer | 356,256 | 0 | 356,256 | 1.1% | 06 May, 2026 |
| 5 | Robert C. Malenka | Director | 316,466 | 0 | 316,466 | 1.0% | 17 Apr, 2026 |
| 6 | Erin Pennock Foff | Chief Medical Officer | 296,906 | 0 | 296,906 | 0.9% | 16 Oct, 2026 |
| 7 | James Woodruff Lillie | Chief Scientific Officer | 198,597 | 0 | 198,597 | 0.6% | 16 Oct, 2026 |
| 8 | Anatol Kreitzer | Chief Discovery Officer | 168,678 | 0 | 168,678 | 0.5% | 16 Oct, 2026 |
| 9 | Jonathan Gillis | Cao And Interim Cfo | 142,315 | 0 | 142,315 | 0.4% | 16 Oct, 2026 |
| 10 | Kristopher Hanson | General Counsel | 128,024 | 0 | 128,024 | 0.4% | 16 Oct, 2026 |
| 11 | Maria C Walker | Director | 62,703 | 0 | 62,703 | 0.2% | 25 Jun, 2026 |
| 12 | Timothy John Garnett | Director | 53,457 | 0 | 53,457 | 0.2% | 25 Jun, 2026 |
| 13 | George Pavlov | Director | 28,932 | 0 | 28,932 | 0.1% | 25 Jun, 2026 |
| 14 | Troy Cox | Director | 0 | 15,620 | 15,620 | 0.0% | 28 Jul, 2026 |
| 15 | Martin Babler | Director | 7,864 | 0 | 7,864 | 0.0% | 25 Jun, 2026 |
| 16 | Nanna Liebach Luneborg | Director | 3,932 | 0 | 3,932 | 0.0% | 25 Jun, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 15 Oct, 2026 | Christopher A. Kroeger | Chief Executive Officer | Disposed S | 73,691 | $8.08 | $595.42K | 1,195,909 | Direct |
| 15 Oct, 2026 | Kristopher Hanson | General Counsel | Disposed S | 9,020 | $8.08 | $72.88K | 128,024 | Direct |
| 15 Oct, 2026 | Anatol Kreitzer | Chief Discovery Officer | Disposed S | 12,248 | $7.84 | $96.02K | 168,678 | Direct |
| 15 Oct, 2026 | Jonathan Gillis | Cao And Interim Cfo | Disposed S | 10,167 | $8.08 | $82.15K | 142,315 | Direct |
| 15 Oct, 2026 | Erin Pennock Foff | Chief Medical Officer | Disposed S | 15,355 | $8.08 | $124.07K | 296,906 | Direct |
| 15 Oct, 2026 | James Woodruff Lillie | Chief Scientific Officer | Disposed S | 11,513 | $8.08 | $93.03K | 198,597 | Direct |
| 16 Sep, 2026 | Kristopher Hanson | General Counsel | Disposed S | 16,509 | $11.67 | $192.66K | 137,044 | Direct |
| 17 Aug, 2026 | Kristopher Hanson | General Counsel | Acquired A | 7,730 | $0.00 | $0 | 153,553 | Direct |
| 17 Aug, 2026 | Erin Pennock Foff | Chief Medical Officer | Acquired A | 13,360 | $0.00 | $0 | 312,261 | Direct |
| 17 Aug, 2026 | Jonathan Gillis | Cao And Interim Cfo | Acquired A | 6,020 | $0.00 | $0 | 150,260 | Direct |
| 17 Aug, 2026 | James Woodruff Lillie | Chief Scientific Officer | Acquired A | 7,730 | $0.00 | $0 | 210,110 | Direct |
| 17 Aug, 2026 | Christopher A. Kroeger | Chief Executive Officer | Acquired A | 23,145 | $0.00 | $0 | 1,269,600 | Direct |
| 17 Aug, 2026 | Anatol Kreitzer | Chief Discovery Officer | Acquired A | 6,020 | $0.00 | $0 | 180,926 | Direct |
| 17 Aug, 2026 | Kristopher Hanson | General Counsel | Acquired A | 31,395 | $0.00 | $0 | 31,395 | Direct |
| 17 Aug, 2026 | Erin Pennock Foff | Chief Medical Officer | Acquired A | 54,240 | $0.00 | $0 | 54,240 | Direct |
| 17 Aug, 2026 | James Woodruff Lillie | Chief Scientific Officer | Acquired A | 31,395 | $0.00 | $0 | 31,395 | Direct |
| 17 Aug, 2026 | Anatol Kreitzer | Chief Discovery Officer | Acquired A | 24,455 | $0.00 | $0 | 24,455 | Direct |
| 17 Aug, 2026 | Jonathan Gillis | Cao And Interim Cfo | Acquired A | 2,222 | $0.00 | $0 | 152,482 | Direct |
| 17 Aug, 2026 | Christopher A. Kroeger | Chief Executive Officer | Acquired A | 93,955 | $0.00 | $0 | 93,955 | Direct |
| 17 Aug, 2026 | Jonathan Gillis | Cao And Interim Cfo | Acquired A | 24,455 | $0.00 | $0 | 24,455 | Direct |